Intelligence Platform
Patents
Browse 991 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7365072
Inhibitors of p38
granted patentUS 7361665
Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
granted patentUS 7358273
Inhibitors of caspases
granted patentUS 7358258
Prodrugs of an ERK protein kinase inhibitor
granted patentUS 7354919
Isoxazole compositions useful as inhibitors of ERK
granted patentUS 7354939
Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto
granted patentUS 7351702
Caspase inhibitors and uses thereof
granted patentUS 7348335
Compositions useful as inhibitors of JAK and other protein kinases
granted patentUS 7345054
Heterocyclic inhibitors of ERK2 and uses thereof
granted patentUS 7329652
Diaminotriazole compounds useful as protein kinase inhibitors
granted patentUS 7329681
Inhibitors of IMPDH enzyme
granted patentUS 7323616
Genetically altered mice deficient in functional caspase-9
granted patentUS 7321063
Sulfonamide inhibitors of aspartyl protease
granted patentUS 7314885
Pyrrole compounds useful as kinase inhibitors
granted patentUS 7312227
Compositions useful as inhibitors of JAK and other protein kinases
granted patentUS 7309716
Benzimidazoles useful as modulators of ion channels
granted patentUS 7304061
Heterocyclic inhibitors of ERK2 and uses thereof
granted patentUS 7304071
Protein kinase inhibitors and uses thereof
granted patentUS 7288624
Inhibitors of interleukin-1Ξ² converting enzyme
granted patentUS 7279476
Pyrazole-derived kinase inhibitors and uses thereof
granted patentUS 7279469
Diaminotriazoles useful as inhibitors of protein kinases
granted patentUS 7276502
Thiazoles useful as inhibitors of protein kinases
granted patentUS 7273885
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted patentUS 7271181
Inhibitors of p38
granted